Inotiv, Inc. to Report First Quarter Fiscal 2022 Financial Results and Host Conference Call on Thursday, February 10, 2022
January 27 2022 - 4:05PM
Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or
“Inotiv”), a leading contract research organization
specializing in nonclinical and analytical drug discovery and
development services and research models and related products and
services, today announced that the Company will issue its financial
results press release for the fiscal 2022 first quarter ended
December 31, 2021, on Thursday, February 10, 2022, after the close
of the stock market and host a conference call the same day at 4:30
p.m. Eastern Time to discuss the results.
Interested parties may participate in the call
by dialing:
- (877) 407-9753 (Domestic)
- (201) 493-6739 (International)
The live conference call webcast will be
accessible in the Investors section of the Company’s web site and
directly via the following
link:https://themediaframe.com/mediaframe/webcast.html?webcastid=cXkN5tYP
For those who cannot listen to the live
broadcast, an online replay will be available in the Investors
section of Inotiv’s web site at:
https://www.inotivco.com/investors/investor-information/.
About the CompanyInotiv, Inc.
is a leading contract research organization dedicated to providing
nonclinical and analytical drug discovery and development services
and research models and related products and services. The
Company’s products and services focus on bringing new drugs and
medical devices through the discovery and preclinical phases of
development, all while increasing efficiency, improving data, and
reducing the cost of taking new drugs to market. Inotiv is
committed to supporting discovery and development objectives as
well as helping researchers realize the full potential of their
critical R&D projects, all while working together to build a
healthier and safer world. Further information about Inotiv can be
found here: https://www.inotivco.com/.
This release may contain forward-looking
statements that are subject to risks and uncertainties including,
but not limited to, risks and uncertainties related to changes in
the market and demand for our products and services, the
development, marketing and sales of products and services, changes
in technology, industry and regulatory standards, the timing of
acquisitions and the successful closing, integration and business
and financial impact thereof, the impact of the COVID-19 pandemic
on the economy, demand for our services and products and our
operations, including the measures taken by governmental
authorities to address the pandemic, which may precipitate or
exacerbate other risks and/or uncertainties, expansion and related
efforts, and various other market and operating risks, including
those detailed in the Company's filings with the U.S. Securities
and Exchange Commission.
Company Contact |
|
Investor Relations |
Inotiv, Inc. |
|
The Equity Group Inc. |
Beth A. Taylor, Chief Financial Officer |
|
Kalle Ahl, CFA |
(765) 497-8381 |
|
(212) 836-9614 |
btaylor@inotivco.com |
|
kahl@equityny.com |
|
|
|
|
|
Devin Sullivan |
|
|
(212) 836-9608 |
|
|
dsullivan@equityny.com |
Inotiv (NASDAQ:NOTV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Inotiv (NASDAQ:NOTV)
Historical Stock Chart
From Apr 2023 to Apr 2024